The Man Who Blew the Whistle on One of the Deadliest Prescription Drugs Ever
by Kathleen Sharp
Blood Feud is the electrifying true tale of Big Pharma's power, regulatory weakness, and the terrifying vulnerability of millions of innocent patients.
The Players
The Drug: Procrit
An anti-anemia drug, this miraculous blood booster was one of the first biotech blockbusters. Developed by Amgen and licensed to a Johnson & Johnson company, the drug was sold by the two companies under the brand names Procrit, Epogen, and Arenesp.
The Underdog: Mark Duxbury, Drug Salesman
Duxbury was the gung-ho salesman for the new biotech division of J&J, an irrepressible character full of jokes. In the early 1990s, he set out to spread the benefits of Procrit, and became a true believer and top seller. But he and his peers were told to steal business from J&J's partner, Amgen. Then came the marketing studies, the off-invoice rebates, doctor payments, and off-label claims. Duxbury tried to stop some of these ruthless programs, but was fired on trumped-up charges. He tried anything to warn the public: testifying in a secret arbitration, joining a class action effort, and filing a whistleblower suit. But he was thwarted at nearly every turn-until the surprising end.
The Best Friend: Dean McClellan, Drug Legend
Dean McClellan was Duxbury's friendly rival. He tried to beat his buddy's record and wound up selling $170 million worth of the drug, becoming a legend. When Duxbury got fired, McClellan tried to distance himself. But as news of Procrit's deadly power started to surface, McClellan agreed to hand over thousands of damning documents and help his friend blow the whistle on J&J.
The Crusader: Jan Schlichtmann, Esq.
Remember Jan Schlichtmann, protagonist of the best-selling book and Oscar nominated movie, A Civil Action. When he learned of Duxbury's mission, he felt the old fire rising in his belly and signed on. Now, he's gambling on yet another long shot, trying to fight on behalf of not just millions of cancer patients, but for every American who overpays for health-care.
"A blockbuster of a story, especially today with Medicare potentially on the chopping block." - Kirkus
This information about Blood Feud was first featured
in "The BookBrowse Review" - BookBrowse's membership magazine, and in our weekly "Publishing This Week" newsletter. Publication information is for the USA, and (unless stated otherwise) represents the first print edition. The reviews are necessarily limited to those that were available to us ahead of publication. If you are the publisher or author and feel that they do not properly reflect the range of media opinion now available, send us a message with the mainstream reviews that you would like to see added.
Any "Author Information" displayed below reflects the author's biography at the time this particular book was published.
Kathleen Sharp is a journalist whose work has appeared in Vanity Fair, The New York Times Magazine, and many other publications; she has won six awards from the Society of Professional Journalists, among other honors. She lives in Santa Barbara, California.

If you liked Blood Feud, try these:
by David Joy
Published 2023
Acclaimed author and "remarkably gifted storyteller" (the Charlotte Observer) David Joy returns with a fierce and tender tale of a father, an addict, a lawman, and the explosive events that come to unite them.
by Jamie Ducharme
Published 2022
A propulsive, eye-opening work of reporting, chronicling the rise of Juul and the birth of a new addiction.
by John Carreyrou
Published 2020
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.
Outside of a dog, a book is man's best friend. Inside of a dog it's too dark to read.
Click Here to find out who said this, as well as discovering other famous literary quotes!
Your guide toexceptional books
BookBrowse seeks out and recommends the best in contemporary fiction and nonfiction—books that not only engage and entertain but also deepen our understanding of ourselves and the world around us.